Advanced NIRS (DCS, TR-NIRS, FD-NIRS)
Diffuse correlation spectroscopy and time/frequency-domain NIRS, research-grade non-invasive techniques that quantify absolute CBF and tissue oxygenation; emerging clinical use in pediatric NICU and CICU.
1. Bedside vignettes: why this matters
Vignette A. Research-protocol preterm, BFi falling pre-IVH
A 25-week preterm, 700 g, on a research protocol for SafeBoosC-style autoregulation monitoring with co-located DCS and TR-NIRS. At 18 hours of life, DCS BFi has fallen 30% over 4 hours while rSO₂ from the cwNIRS arm is only marginally changed. The team correlates: MAP has crept down from 32 to 25 mmHg without obvious clinical signs. Fluid bolus and dopamine restore MAP; BFi recovers. Routine TFUS the next day shows no IVH. The combined absolute-flow + tissue-oxygenation bundle caught a perfusion event that the routine cwNIRS would have missed.
Vignette B. Adolescent post-arrest, CBFi and CMRO₂ tracking
A 14-year-old post-arrest, day 1 post-rewarming. The neuro-monitoring team applies a DCS + FD-NIRS combined sensor over the frontal scalp. Calculated CMRO₂_NIRS = 1.2 mL O₂/100 g/min (markedly low; healthy 4–5). Combined with bilateral absent N20 and suppressed cEEG, the metabolic data add quantitative support to the clinical prognostic call. The non-invasive metabolic signal complements the electrophysiology and the clinical exam.
Vignette C. Pediatric cardiac surgery, CBFi during DHCA
A 2-month-old with single-ventricle physiology undergoing Norwood-stage repair under deep hypothermic circulatory arrest. Combined DCS + FD-NIRS is used research-grade during the procedure. During DHCA, CBFi falls to near-zero; rSO₂ falls slowly; on rewarming, CBFi recovers in advance of rSO₂. The team correlates the duration of low-CBFi periods with post-operative neurologic outcomes, anchoring future protocol development. The modality offers a non-invasive CBF surrogate where invasive monitoring is impossible.
2. What advanced NIRS is, and what it is not
Routine clinical NIRS (cwNIRS) measures the relative change in haemoglobin concentrations over a spatially-fixed banana-shaped tissue zone, using two-wavelength absorbance. The output (rSO₂) is relative and uncalibrated: a normalised ratio of HbO to HbT, accurate for trend but not absolute, with substantial scalp-contamination problems.
Advanced NIRS techniques fix specific limitations of cwNIRS.
2.1 Diffuse correlation spectroscopy (DCS)
DCS uses a coherent (laser) light source and measures the temporal autocorrelation of speckle intensity at a detector ~ 2–3 cm from the source. Light photons scattered by moving red blood cells lose coherence; the rate at which the autocorrelation decays is proportional to the local blood-flow index (BFi):
where Γ is proportional to BFi × scattering coefficient. The output is BFi in cm²/s units; with assumptions about haematocrit, scattering, and (optionally) calibration against arterial pressure pulse, an absolute CBF estimate can be derived.
2.2 Time-resolved NIRS (TR-NIRS)
TR-NIRS uses short (~ 50–100 ps) light pulses and time-resolved photon detection. The time-of-flight distribution allows separation of photons that have travelled short (scalp) and long (brain) paths, yielding depth-resolved absorbance. Combined with the modified Beer-Lambert law, this gives absolute HbO and HbR concentrations and therefore true rSO₂.
2.3 Frequency-domain NIRS (FD-NIRS)
FD-NIRS modulates the light source at radio frequencies (~ 100 MHz) and measures the phase shift and amplitude attenuation at the detector. From these, absolute optical properties of the tissue (absorption and scattering coefficients) are determined, again giving absolute HbO and HbR. FD-NIRS is generally simpler hardware than TR-NIRS for the same absolute output.
2.4 The combined DCS + TR/FD-NIRS bundle
The combination is powerful:
- DCS gives a continuous non-invasive flow surrogate (BFi).
- TR/FD-NIRS gives absolute tissue oxygenation (true rSO₂, HbO, HbR).
- Together they allow a non-invasive Fick-style computation of CMRO₂:
This is the strongest advance over routine cwNIRS: continuous, non-invasive, regional, absolute CBF and CMRO₂ at the bedside.
What advanced NIRS does well
- Continuous, non-invasive, regional: no needle, no transport, repeatable.
- Absolute or quantitative flow / oxygenation: anchors the trend in physiological units.
- Pediatric-friendly: small head, thin skull, ideal optical geometry.
- Bedside CMRO₂: a non-invasive metabolic signal where invasive measurement is unfeasible.
What advanced NIRS cannot do
- Be cheap or compact yet: most systems are research-grade carts.
- Replace cwNIRS for routine trends: the simpler, cheaper modality still dominates the clinical bedside.
- Be reliable through thick scalp: adolescent and adult skull / scalp thickness reduces signal-to-noise.
- Match invasive PbtO₂ / TD-CBF for absolute accuracy: still a research-grade approximation.
- Detect focal injury well: spatial resolution is poor (cm scale); regional, not focal.
Advanced NIRS combines the strengths of cwNIRS (non-invasive, bedside) with a quantitative flow channel that routine NIRS lacks. Where the hardware and expertise are available, the bundle gives a non-invasive proxy for what would otherwise require invasive PbtO₂ + TD-CBF probes.
- Pediatric heads are ideal for NIRS: thinner skull, less scalp, shorter source-detector distances. The signal-to-noise advantage drives the pediatric-leaning literature.
- Preterm IVH risk and HIE prognostication are the strongest pediatric applications.
- Pediatric CICU during CPB and DHCA is a growing application area.
- Routine pediatric clinical use is still research-grade, but the trend is toward bedside adoption in dedicated NICU and CICU programmes.
3. Anatomy and probe geometry
3.1 Source-detector geometry
Pediatric: source-detector separation 1.5–2.5 cm for shallow brain interrogation; 2.5–3 cm for deeper. Adult: 3–4 cm separation; deeper banana but more scalp contamination.
3.2 Probe placement
- Cerebral monitoring: bilateral frontal placement (over Fp1, Fp2 or over forehead lateral to midline) is the standard.
- Cerebral plus somatic: simultaneous flank or thigh placement gives differential brain vs body oxygenation, useful in CHD and septic-shock contexts.
- Probe security: adhesive patches; head wraps in active patients; care to avoid pressure injury under the optode.
3.3 Calibration and validation
- Phantom calibration: regular calibration against tissue-mimicking phantoms is standard for research-grade systems.
- Cross-validation against established modalities: DCS BFi vs MRI ASL CBF; TR-NIRS rSO₂ vs SjvO₂ or PbtO₂; published validation studies in pediatric and adult cohorts.
4. The signal: what each technique reports
4.1 cwNIRS (reference)
- Output: relative HbO, HbR, HbT changes; ratio metric rSO₂ (%).
- Limitations: relative only, scalp contamination, pathlength assumptions.
4.2 DCS
- Output: BFi (cm²/s); CBFi calibrated against arterial pressure.
- Strengths: continuous, non-invasive flow surrogate; high temporal resolution (~ Hz).
- Limitations: hardware complexity; sensitivity to motion; intermediate scalp contamination.
4.3 TR-NIRS
- Output: absolute HbO and HbR (µM); true rSO₂; depth-resolved absorbance.
- Strengths: absolute concentrations; depth resolution.
- Limitations: complex hardware; lower temporal resolution (~ 1 Hz).
4.4 FD-NIRS
- Output: absolute optical properties; absolute HbO, HbR; rSO₂.
- Strengths: simpler hardware than TR-NIRS; absolute output.
- Limitations: phase-shift measurement requires good signal-to-noise; less depth-resolved than TR-NIRS.
4.5 Combined DCS + TR/FD-NIRS
- Output: BFi + absolute HbO + absolute HbR + non-invasive CMRO₂ estimate.
- Strengths: complete non-invasive flow / oxygenation / metabolism bundle.
- Limitations: research-grade hardware; trained operators; data analysis pipeline.
5. The numbers to record: the advanced-NIRS six-pack
| Variable | Symbol | What to record |
|---|---|---|
| Blood flow index | BFi (cm²/s) | Primary DCS output; with baseline reference |
| Calibrated CBFi | CBFi (relative units) | Calibrated BFi against arterial pulse |
| Absolute HbO and HbR | µM | TR/FD-NIRS output |
| Absolute rSO₂ | % | Derived from HbO and HbR |
| Non-invasive CMRO₂ estimate | mL O₂/100 g/min | Combined DCS + NIRS Fick computation |
| Trend over time | ΔBFi / Δrso2 over hours | The bedside read |
Document: probe placement and source-detector separation, scalp thickness if measurable, recent imaging, sedation, body temperature, MAP, and any clinical interventions.
6. What is normal? Age- and condition-banded reference
Advanced NIRS reference values are emerging; absolute thresholds are evolving. The pediatric data are stronger than adult.
| Age band | DCS BFi (cm²/s × 10⁻⁹) | TR/FD-NIRS rSO₂ (%) | Estimated CMRO₂_NIRS (mL O₂/100 g/min) |
|---|---|---|---|
| Preterm 26–32 wk | 1–3 | 55–75 | 0.8–1.5 |
| Term newborn | 3–6 | 60–80 | 1.5–2.5 |
| 6 months | 8–14 | 65–80 | 3–4 |
| 1–3 years | 12–18 | 65–80 | 4–5 |
| 4–10 years | 12–18 | 65–80 | 4–5 |
| Adolescent | 8–14 | 65–75 | 3.5–4.5 |
| Adult | 6–12 | 60–75 | 3–3.5 |
Sources: . Reference values vary by device, source-detector separation, and analysis algorithm; centre-specific calibration is the rule.
Pediatric reference data are the most developed for advanced NIRS, reflecting the optical advantage of pediatric heads and the strong NICU / CICU research programmes. Adult reference data are sparser; absolute thresholds in adults should be applied with caution.
7. What is abnormal? Pattern library
| Pattern | Bedside meaning | What to do |
|---|---|---|
| BFi falling > 25% over hours | Evolving regional perfusion deficit | Check MAP, autoregulation, position; intervene |
| Absolute rSO₂ falling > 10 points | Decreased O₂ saturation, reduced delivery or increased extraction | Address the cause (MAP, Hb, SaO₂, sedation, fever) |
| High BFi with normal SaO₂ | Hyperaemia; consider seizure, fever, sepsis | cEEG; treat cause |
| High BFi with collapsed rSO₂ | Luxury perfusion with metabolic collapse | Severe injury; pair with cEEG, SSEP |
| Combined CMRO₂_NIRS markedly low | Metabolic suppression (severe injury, deep coma) | Multimodal corroboration |
| BFi recovering with intervention | Therapeutic response | Continue strategy |
| Asymmetry > 30% between probes | Unilateral perfusion deficit | Imaging; clinical exam |
| Discordance with cwNIRS | Algorithm or scalp-contamination issue | Prefer advanced NIRS where calibrated |
| Loss of signal | Probe displacement, hair / skin obstruction | Recheck placement; clean optical contact |
| Signal during DHCA | Allows monitoring during circulatory arrest | Document; correlate with rewarming and outcomes |
8. Try it: interactive widget
Advanced NIRS techniques do not currently have dedicated interactive widgets on this platform. The closest analogue is the routine NIRS widget, which illustrates the photon-path geometry and the rSO₂ trend; the DCS and TR/FD-NIRS extensions are conceptual extensions of the same geometry.
9. Management: how advanced NIRS changes decisions
9.1 Preterm IVH risk reduction
SafeBoosC-style autoregulation monitoring uses cwNIRS as the primary signal. Advanced NIRS adds:
- DCS BFi as a quantitative perfusion channel that detects perfusion events the rSO₂ may miss.
- TR/FD-NIRS rSO₂ as a true absolute saturation, allowing centre-to-centre comparability.
- Combined CMRO₂ as a metabolic signal that may identify oligemia before structural injury appears.
The SafeBoosC-III trial (cwNIRS-only) did not show outcome improvement; advanced-NIRS trials are in design / early phase.
9.2 HIE prognostication
In cooled HIE neonates, advanced NIRS adds a non-invasive metabolic signal:
- Reduced CMRO₂_NIRS over the first 72 hours correlates with severity of injury and outcome.
- The non-invasive bundle complements aEEG, MRI, and clinical exam in the neuroprognostic stack.
- The signal is most informative in the early reperfusion phase (12–48 hours post-arrest), where the trajectory of recovery vs deterioration becomes visible.
9.3 Pediatric cardiac surgery and CICU
Continuous DCS during CPB and DHCA gives a flow signal where invasive measurement is impossible:
- Duration of low-CBFi periods correlates with neurodevelopmental outcome.
- DHCA protocols can be informed by intraoperative BFi.
- Post-operative CICU monitoring uses combined cwNIRS + DCS for trend.
9.4 Post-cardiac-arrest
Combined DCS + TR/FD-NIRS at 24–72 hours post-arrest yields a non-invasive CBF / CMRO₂ bundle that adds to the neuroprognostic dataset. The clinical pathway integrates with EEG, NPI, SSEP, MRI, and clinical exam.
Decision support, not a clinical protocol. Advanced NIRS is research-grade in most settings. Application requires centre-specific calibration, trained operators, and integration into a research or quality-improvement framework.
10. Clinical contexts
10.1 Preterm IVH prevention and SafeBoosC paradigm
The largest evidence base for advanced NIRS is in the preterm population. cwNIRS-guided care (SafeBoosC, SafeBoosC-III) has not improved outcome at the primary endpoint; advanced-NIRS techniques may bring the autoregulation signal closer to direct measurement and improve interventional precision. The next-generation trials will likely incorporate DCS and TR-NIRS.
10.2 Neonatal HIE and post-arrest
Advanced NIRS adds a non-invasive metabolic channel to the neonatal HIE monitoring bundle (aEEG + cwNIRS + MRI + clinical exam). The combined CMRO₂_NIRS signal complements electrophysiology and imaging. Pediatric post-arrest applications include the THAPCA-era multimodal stack with emerging advanced NIRS adoption.
10.3 Pediatric cardiac surgery and CICU
A major growth area. Combined DCS + FD-NIRS during CPB / DHCA / ECMO provides bedside continuous CBF and oxygenation surrogates. CICU monitoring uses cwNIRS as routine; advanced NIRS adds research-grade quantitative perfusion.
10.4 Severe TBI
Advanced NIRS in pediatric and adult severe TBI is less developed than in neonatal applications. cwNIRS is part of multimodal monitoring; advanced NIRS adds non-invasive CBF / CMRO₂ where invasive monitoring is not in place.
10.5 Aneurysmal SAH and DCI
Adult-cwNIRS data for DCI detection are mixed; advanced NIRS is research-grade. The combined non-invasive flow / oxygenation bundle is being explored as a DCI-detection adjunct.
10.6 Pediatric arterial ischaemic stroke
cwNIRS over the affected hemisphere may show desaturation in acute MCA-territory infarct. Advanced NIRS adds CBFi to confirm and quantify; research-grade.
10.7 Pediatric ECMO
Combined cwNIRS + DCS during ECMO supports detection of perfusion events at cannulation and during pump flow changes. Routine cwNIRS is standard; advanced NIRS is research-grade in pediatric ECMO.
10.8 Bacterial meningitis with raised ICP
Non-invasive monitoring with combined cwNIRS + DCS may track perfusion deficits in severe meningitis with vasculitis or vasospasm. Research-grade.
10.9 Brain-death determination (supportive)
In brain death, BFi falls to near-zero and rSO₂ approaches arterial saturation. This is supportive evidence; the World Brain Death Project framework requires the clinical exam and apnoea test with formal ancillary tests (CTA, TCD, EEG, BAER), not advanced NIRS alone.
11. Multimodal integration: advanced NIRS in the MMM/MNM stack
| Pair with… | What you gain | Worked scenario |
|---|---|---|
| cwNIRS | Routine trend + advanced quantitation | Pediatric NICU bundle |
| aEEG / cEEG | Electrophysiology + non-invasive flow + non-invasive O₂ | HIE monitoring bundle |
| TCD | Large-vessel velocity + microvascular flow | TCD vs ICP vasospasm |
| PbtO₂ / TD-CBF (where available) | Validate non-invasive against invasive | Research validation |
| Clinical exam / NPI | Cortical and brainstem function + perfusion / metabolism | Discordance triage |
| MRI / ASL | Tomographic CBF correlation | HIE day 4–7 |
| Microdialysis | Direct metabolism + non-invasive metabolism | Research bundle |
12. Setup and technique
12.1 Equipment
- DCS system: research-grade systems from MetaOx, ISS, or research-built (custom coherent laser source, avalanche photodiode detector, correlator).
- TR-NIRS system: research-grade (PicoQuant, Hamamatsu time-correlated single-photon counting).
- FD-NIRS system: ISS Imagent, MetaOx (RF-modulated source, phase-shift detection).
- Combined optodes: increasingly available; some research groups build custom combined sensors.
- Trained operator: technician + biomedical engineer + data analyst; the modality is not plug-and-play.
12.2 Placement: 6-step protocol
- Site selection: bilateral frontal (Fp1, Fp2) or hemisphere of interest. Avoid hairy scalp where possible; clip hair if necessary.
- Skin prep: clean with alcohol; gentle abrasion not usually needed.
- Optode placement: hydrogel pads or custom adhesive holders; secure with light tape or head wrap.
- Source-detector separation: 1.5–2.5 cm for pediatric; 2.5–4 cm for adult; document on chart.
- Verify signal: run a brief acquisition; check signal-to-noise; reposition if poor.
- Begin continuous recording: sampling at 1–10 Hz depending on system; data piped to analysis machine.
12.3 Calibration
- Phantom calibration at the start of each session for absolute measurements.
- Within-patient baseline in the first 30–60 minutes for trend analysis.
- Periodic re-check of phantom values to detect drift.
- Cross-validation against established modalities (cwNIRS, TCD, PbtO₂ where available).
12.4 Analysis pipeline
- Real-time processing for BFi, rSO₂, HbO, HbR; data piped to bedside display.
- Post-hoc analysis for CMRO₂_NIRS computation and quality control.
- Storage: raw correlation data, time-resolved photon counts, or phase-shift data archived for offline analysis.
- Quality flags: motion artefact, optode displacement, low signal-to-noise marked automatically.
12.5 Operational pitfalls
- Hair: dense scalp hair attenuates signal; clip or shave where possible.
- Pressure injury: long-term placement of optodes can cause skin breakdown; rotate sites or use cushioned holders.
- Motion artefact: pediatric patients move; sedation or paralysis improves signal quality.
- Ambient light: bright sunlight or surgical lamps can contaminate; cover with light-blocking material.
- Cable management: research-grade systems have multiple cables; tangling and pulling on optodes destroys signal.
12.6 Documentation
The chart entry pairs the advanced NIRS values with the clinical context, the source-detector separation, the calibration status, and any quality flags. Without these, the data are not interpretable in retrospect.
13. Pitfalls
- Hardware is bulky and expensive: most centres do not have dedicated advanced-NIRS equipment.
- Calibration drift: regular phantom calibration is required.
- Hair attenuates signal: pediatric advantage is partly because newborn and infant heads have less hair.
- Scalp contamination is reduced but not eliminated: TR-NIRS and FD-NIRS depth-resolve but still mix scalp and brain.
- Motion artefact: pediatric movement degrades signal; sedation or paralysis helps.
- Reference values are emerging: centre-specific calibration is the rule, not the exception.
- Algorithm transparency: different analysis pipelines produce different BFi values; consistency within a study or centre matters more than absolute comparability.
- Adult signal-to-noise is worse than pediatric due to thicker scalp and skull; absolute thresholds in adults are less reliable.
- Probe placement matters: shifting an optode 1 cm changes the interrogated tissue; document and maintain consistent placement.
- CMRO₂_NIRS is an estimate: the non-invasive Fick computation has multiple assumptions (haematocrit, scattering, calibration); validate against invasive measurement where possible.
14. Combine with…
- NIRS / cwNIRS: the routine bedside; advanced NIRS extends the same concept.
- TCD: large-vessel velocity; microvascular complement.
- PbtO₂: invasive tissue oxygenation; validates non-invasive.
- Direct CBF: invasive regional CBF; validates non-invasive.
- aEEG / cEEG: electrophysiology + non-invasive flow / O₂.
- Foundations: NIRS principles: the physics underlying all NIRS modalities.
- Foundations: cerebral metabolism: the CMRO₂ context.
- Integration: HIE monitoring bundle: pediatric neuroprognostic stack.
15. Evidence summary
| Topic | Source | Grade |
|---|---|---|
| Original NIRS description | foundational | |
| Lovett 2024 advanced NIRS review | review | |
| Andrade 2021 brain temp / NIRS context | review | |
| Davies pediatric NIRS | B | |
| Andresen neonatal NIRS | B | |
| Lee ND-NIRS | C | |
| SafeBoosC-III primary | A | |
| SafeBoosC-III secondary | A | |
| SafeBoosC-II feasibility | B | |
| Greisen NIRS oversight | review | |
| HIE NICHD cooling trial | A | |
| AHA pediatric post-arrest | expert | |
| THAPCA-OH pediatric | A | |
| Pediatric brain injury post-arrest | review | |
| Pediatric severe TBI (BTF 4th ed.) | expert | |
| Pediatric neurocritical care review | review | |
| AHA SAH guidelines | expert | |
| Pediatric AIS / thrombectomy | expert | |
| ECMO neuro outcomes | C | |
| BOOST-II / BOOST-III | A | |
| Brain-death determination | expert | |
| Pediatric MMM review (Laws 2022) | review |
16. Recent literature (2022–2025)
- Lovett 2024 (advanced NIRS review): synthesises DCS, TR-NIRS, and FD-NIRS for pediatric clinical translation.
- Andrade 2021 (review): integrates brain temperature, NIRS, and metabolism in the bedside context.
- SafeBoosC-III (Hansen 2023): cwNIRS-guided autoregulation monitoring in preterm did not improve primary outcome; secondary signals and the case for advanced NIRS in next-generation trials remain active. The pre-planned 2-year follow-up (Rasmussen 2023) extends outcome ascertainment.
- Pediatric MMM review (Laws 2022): advanced NIRS listed as emerging research modality with strong potential in pediatric NICU and CICU.
- Slovis 2024 (pediatric brain injury post-arrest): advanced NIRS as a future channel in post-arrest multimodal monitoring.
- Pediatric MMM review (Laws 2022): describes advanced NIRS as a research modality with high potential for pediatric translation.
17. Self-check
References
- Lovett ME, O'Brien NF. A Review of Noninvasive Neuromonitoring Modalities in Children Part I: Pupillometry, Near-Infrared Spectroscopy, and Transcranial Doppler Ultrasonography. Neurocritical Care 2024;38(1):130-146. doi:10.1007/s12028-023-01730-4 link
- Brasil S, Solla DJF, Nogueira RC, Teixeira MJ, Malbouisson LMS, Paiva WS. A Novel Noninvasive Technique for Intracranial Pressure Waveform Monitoring in Critical Care. Journal of Personalized Medicine 2021;11(12):1302. doi:10.3390/jpm11121302 link
- Hansen ML, Pellicer A, Hyttel-Sørensen S, et al. (SafeBoosC-III Trial Group). Cerebral oximetry monitoring in extremely preterm infants. NEJM 2023;388(16):1501–1511. doi:10.1056/NEJMoa2207554 link
- Topjian AA, Scholefield BR, Pinto NP, et al.. Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association. Circulation 2019;140(6):e194-e233. doi:10.1161/CIR.0000000000000697 link
- Slovis JC, Bach A, Beaulieu F, et al.. Neuromonitoring after Pediatric Cardiac Arrest: Cerebral Physiology and Injury Stratification. Neurocritical Care 2024;40(1):99-115. doi:10.1007/s12028-023-01685-6 link
- Davies DJ, Su Z, Clancy MT, et al.. Near-infrared spectroscopy in the monitoring of adult traumatic brain injury: a review. Journal of Neurotrauma 2015;32(13):933-941. doi:10.1089/neu.2014.3748 link
- Andresen B, Greisen G, Hyttel-Sorensen S. Comparison of INVOS 5100C and Nonin SenSmart X-100 oximeter performance in preterm infants with spontaneous apnea. Pediatric Research 2020;87(7):1244-1250. doi:10.1038/s41390-020-0752-6 link
- Lee JK, Kibler KK, Benni PB, et al.. Cerebrovascular reactivity measured by near-infrared spectroscopy. Stroke 2009;40(5):1820-1826. doi:10.1161/STROKEAHA.108.536094 link
- Hyttel-Sørensen S, Pellicer A, Alderliesten T, et al.. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ 2015;350:g7635. doi:10.1136/bmj.g7635 link
- Greisen G. Cerebral oximetry in preterm infants, to use or not to use, that is the question. Frontiers in Pediatrics 2022;6:376. doi:10.3389/fped.2021.747660 link
- Shankaran S, Laptook AR, Ehrenkranz RA, et al.. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. NEJM 2005;353(15):1574-1584. doi:10.1056/NEJMcps050929 link
- Moler FW, Silverstein FS, Holubkov R, et al.. Therapeutic hypothermia after out-of-hospital cardiac arrest in children (THAPCA-OH). NEJM 2015;372(20):1898-1908. doi:10.1056/NEJMoa1411480 link
- Lorusso R, Taccone FS, Belliato M, et al.. Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessments. Minerva Anestesiologica 2017;83(10):1061-1074. doi:10.23736/s0375-9393.17.11911-5 link
- Kochanek PM, Tasker RC, Carney N, et al.. Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines, Executive Summary. Pediatric Critical Care Medicine 2019;20(3S):S1-S82. doi:10.1097/PCC.0000000000001736 link
- Okonkwo DO, Shutter LA, Moore C, et al.. Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial. Critical Care Medicine 2017;45(11):1907-1914. doi:10.1097/CCM.0000000000002619 link
- Bernard F, Barsan W, Diaz-Arrastia R, et al.. Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST-3): a multicentre, randomised, blinded-endpoint, comparative effectiveness study of brain tissue oxygen and intracranial pressure monitoring versus intracranial pressure alone. BMJ Open 2022;12(3):e060188. doi:10.1136/bmjopen-2021-060188 link
- Hoh BL, Ko NU, Amin-Hanjani S, et al.. Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 2023;54(7):e314-e370. doi:10.1161/str.0000000000000449 link
- Rass V, Helbok R. How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid haemorrhage. Current Opinion in Critical Care 2021;27(2):103-114. doi:10.1097/mcc.0000000000000798 link
- Ferriero DM, Fullerton HJ, Bernard TJ, et al.. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke 2019;50(3):e51-e96. doi:10.1161/STR.0000000000000183 link
- Sun LR, Harrar D, Drocton G, et al.. Mechanical Thrombectomy for Acute Ischemic Stroke. Stroke 2020;51(10):3174-3181. doi:10.1161/STROKEAHA.120.029698 link
- Pisano DV, Ortoleva JP, Wieruszewski PM. Short-Term Neurologic Complications in Patients Undergoing Extracorporeal Membrane Oxygenation Support: A Review on Pathophysiology, Incidence, Risk Factors, and Outcomes. Pulmonary Therapy 2024. doi:10.1007/s41030-024-00265-z link
- Tunkel AR, Hartman BJ, Kaplan SL, et al.. Practice guidelines for the management of bacterial meningitis (IDSA). Clinical Infectious Diseases 2004;39(9):1267–1284. doi:10.1086/425368 link
- Tunkel AR, Glaser CA, Bloch KC, et al.. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2008;47(3):303-327. doi:10.1086/589747 link
- Greer DM, Shemie SD, Lewis A, et al.. Determination of Brain Death/Death by Neurologic Criteria. JAMA 2020;324(11):1078-1097. doi:10.1001/jama.2020.11586 link
- Nakagawa TA, Ashwal S, Mathur M, et al.. Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations. Critical Care Medicine 2011;39(9):2139-2155. doi:10.1097/CCM.0b013e31821f0d4f link
- Laws JC, Jordan LC, Pagano LM, Wellons JC, Wolf MS. Multimodal Neurologic Monitoring in Children With Acute Brain Injury. Pediatric Neurology 2022;129:62-71. doi:10.1016/j.pediatrneurol.2022.01.006 link
- Jöbsis FF. Noninvasive infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977;198(4323):1264–1267. doi:10.1126/science.929199 link
- Smith CA, Rohlwink UK, Mauff K, et al.. Cerebrovascular Pressure Reactivity Has a Strong and Independent Association With Outcome in Children With Severe Traumatic Brain Injury. Critical Care Medicine 2023;51(5):573-583. doi:10.1097/CCM.0000000000005815 link
- Rasmussen MIS, et al.. Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial. Trials 2023;24:653. doi:10.1186/s13063-023-07653-x link